Skip to main content Skip to main navigation menu Skip to site footer
PAGEPress
  • Bluesky
  • X
  • LinkedIn
Confinia Cephalalgica
  • Search
  • Contacts
  • News
  • Register
  • Login
  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current
  • Archives
  • Copyright
  • Search
  • Contacts
  • News
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters Clear filters
Published After
Published Before

Search Results

6 results for “M. Prudenzano”

  • P034 | BODY WEIGHT CHANGES DURING ATOGEPANT THERAPY: A CASE REPORT AND NARRATIVE REVIEW OF THE METABOLIC ROLE OF CGRP

    C. Rita Tamborino, G. Difonzo, F. Domenico Pellicano, A. Fallacara, D. Paolicelli, M. Pia Prudenzano | Headache Center, “L. Amaducci” Neurological Clinic, Policlinico General Hospital, Bari, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15990

    • 0 abstract views
    • 0 PDF
  • OC18 | LONG-TERM EFFECTIVENESS, SAFETY AND TOLERABILITY OF ATOGEPANT IN THE PREVENTION OF MIGRAINE: A MULTICENTRIC, PROSPECTIVE OBSERVATIONAL, REAL WORLD STUDY (THE 48-WEEK STAR STUDY)

    F. Vernieri1|2, L. Francesco Iannone3, M. Marcosano1|2, L. Fofi1, F. Lo Castro4, G. Sebastianelli5, F. De Santis6, M. Corrado7, R. Ornello6, L. Grazzi8, D. Antonio Montisano8, F. De Cesaris9, A. Munafò9, G. Avino10, M. Trimboli11, M. Albanese12, A. Russo13, M. Silvestro13, G. Dalla Volta14, M. Romozzi15, P. Calabresi15, A. Boccalini4, P. Merlo16, M. Pia Prudenzano17, M. Rosaria Valente18, I. Rainero19, G. Giuliani20, M. Altieri20, A. Doretti21, G. Vaghi7|22, F. Pistoia6, D. Ferrandi23, S. Battistini24, G. Coppola5, S. Guerzoni4, S. Sacco6|25, C. Tassorelli7|22, C. Altamura1|2 | 1Headache and Neurosonology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy; 2Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Italy; 3Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; 4Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, Italy; 5Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Latina, Italy; 6Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 7Headache Science and Neurorehabilitation Centre, IRCCS Mondino Foundation, Pavia, Italy; 8Headache Center IRCCS Fondazione Istituto Neurologico "Carlo Besta", Italy; 9Headache center and clinical pharmacology, AOU Careggi, Firenze, Italy; 10Neurology Unit, Ospedale Santo Stefano, USL Toscana Centro, Prato, Italy; 11Azienda Ospedaliera-universitaria "Renato Dulbecco", Catanzaro, Italy; 12Department of Systems Medicine, University of Rome Tor Vergata, Italy; 13Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Italy; 14U.O Neurologia, Istituto Clinico Città di Brescia, Gruppo San Donato, Italy; 15Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; 16UO di Neurologia, Humanitas Gavazzeni, Bergamo, Italy; 17Clinica Neurologica "L. Amaducci", Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Italy; 18Clinica Neurologica ASUFC, Dipartimento di Medicina DMED Università di Udine, Italy; 19Headache Center, Department of Neuroscience, University of Torino, Italy; 20Department of Human Neuroscience, Sapienza University of Rome, Italy; 21IRCCS Istituto Auxologico Italiano, Milano, Italy; 22Department of Brain and Behavioural Sciences, University of Pavia, Italy; 23SC Neurologia, Azienda Ospedaliero Universitaria Santi Antonio e Biagio, Alessandria, Italy; 24Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; 25Neurology and Stroke Unit, ASL 1 Abruzzo, Avezzano-Sulmona-L’Aquila, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15956

    • 0 abstract views
    • 0 PDF
  • P023 | SUSTAINED CLINICAL RESPONSE TO ATOGEPANT AFTER FAILURE OF FOUR ANTI-CGRP MONOCLONAL ANTIBODIES IN HIGHLY RESISTANT CHRONIC MIGRAINE

    G. Difonzo, C. Rita Tamborino, F. Domenico Pellicano, A. Fallacara, D. Paolicelli, M. Pia Prudenzano | Headache Center, “L. Amaducci” Neurological Clinic, Policlinico General Hospital, Bari, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15979

    • 0 abstract views
    • 0 PDF
  • P032 | IMPROVEMENT IN DEPRESSIVE AND ANXIETY SYMPTOMS DURING EPTINEZUMAB TREATMENT: A POST-HOC ANALYSIS FROM THE TACHIS STUDY

    E.M. Piella1, A.M. Chiarandon1, V. Batti1, D.A. Montisano2, L. F. Iannone3, C. Fasano4, G. Sebastianelli5, G. Coppola5, D. Ferrandi6, C. Lanni7, M.P. Prudenzano8, M. De Tommaso9, P. Merlo10, A. Viganò10, F. De Cesaris11, A. Chiarugi11, A. Munafò11, F. Pistoia12, R. Ornello12, S. Sacco12, A. Doretti13, L. Grazzi2, F. Lo Castro14, R. Allamprese14, R. De Icco15|16, G. Vaghi15|16, C. Tassorelli15|16, G. Avino17, M. Romozzi18, C. Vollono18, P. Calabresi18, S. Battistini19, A. Rufa19, M. Albanese20, M. Trimboli21, G. Carlucci4, M. Silvestro22, A. Russo22, M. Valente23, L. Fofi24, M. Marcosano24, P. Geppetti25, C. Altamura24, F. Vernieri24, E. Rubino1, I. Rainero1, S. Guerzoni14 | 1Department of Neuroscience “Rita Levi Montalcini”, University of Turin, Italy; 2Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy; 3Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; 4NEUROFARBA Department, University of Florence - Neurologia, AOU Careggi, Italy; 5Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Latina, Italy; 6AOU Alessandria, SC Neurologia, Italy; 7Psicologia AOU Alessandria, Italy; 8Clinica Neurologica "L. Amaducci", Azienda Ospedaliero-Universitaria Consorziale di Bari, Italy; 9Neurophysiopathology Unit, Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Italy; 10UO di Neurologia, Humanitas Gavazzeni, Bergamo, Italy; 11Headache center and Clinical pharmacology unit, AOU Careggi, Florence, Italy; 12Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; 13Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milano, Italy; 14Digital and Predictive Medicine, Pharmacology, Clinical Metabolic Toxicology-Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico, Modena, Italy; 15Department of Brain and Behavioral Sciences, University of Pavia, Italy; 16Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy; 17SOC Neurologia, Ospedale di Prato, Italy; 18Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; 19Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; 20Unit of Neurology, Department of Systems Medicine, University of Rome Tor Vergata, Italy; 21Headache Center, Unit of Neurology, AOU Renato Dulbecco, Catanzaro, Italy; 22Inter-departmental Program of Headache Medicine and Primary Pain Syndromes, Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy; 23DMED, University of Udine and Clinical Neurology, Udine University Hospital, Italy; 24Fondazione Policlinico Universitario Campus Bio-Medico, Roma e Università Campus Bio-Medico di Roma, Italy; 25Department of Molecular Pathobiology and Pain Research Center, College of Dentistry, New York University, NY, USA

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15988

    • 0 abstract views
    • 0 PDF
  • P078 | THE PATIENT JOURNEY OF RESISTANT AND REFRACTORY MIGRAINE: RESULTS FROM THE REFINE STUDY

    I. Gragnaniello1, S. Sacco1, A. Onofri1, C. Rosignoli1, V. Caponnetto1, D. Bayar2, M. Braschinsky3, M. Carnovali4, M. Gentile5, R. Gil-Gouveia6, G. Iaccarino7, C. Lampl8, A. Leheste3, P. Martelletti9, C. Mazzanti9, D. Mitsikostas10, A. Muñoz-Vendrell11, R. Oliveira6, A. Ozge2, I. Pavão Martins12, P. Pozo-Rosich11, M. Prudenzano5, K. Ryliskiene13, M. Sanchez del Rio14, J. Vainauskienė13, F. Vernieri7, M. Waliszewska-Prosół, Z. Katsarava4, A. Sinclair16, R. Ornello1 | 1University of L'Aquila, Department of Applied Clinical Sciences and Biotechnology, Italy; 2Mersin University Faculty of Medicine, Department of Neurology, Turkey; 3Headache Clinic, Tartu, Estonia; 4Evangelical Hospital, Unna, Germany; 5Centro Cefalee - Clinica Neurologica "L. Amaducci", Azienda Ospedaliero-Universitaria Policlinico Consorziale di Bari, Italy; 6Hospital da Luz - Center for Interdisciplinary Research in Health, Universidade Católica Portuguesa, Lisbon, Portugal; 7Cefalee e Neurosonologia-Policlinico Universitario Campus Bio-medico, Rome, Italy; 8Department of Neurology and Headache Medical Centre, Konventhospital Barmherzige Brüder Linz, Austria; 9University Sapienza, Rome, Italy; 10First Neurology Department, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Greece; 11Headache Unit and Research Group Vall d'Hebron University Hospital and Institute of Research, Universitat Autonoma de Barcelona, Spain; 12Faculdade de Medicine and Hospital Universitário de Santa Maria, Centro Hospitalar; Hospital Cuf Tejo, Lisbon, Portugal; 13Vilnius University Centre of Neurology, Kardiolitos klinikos Centre of Neurology, Lithuania; 14Clinica Universidad de Navarra, Madrid, Spain; 15Department of Neurology, Wroclaw Medical University, Poland; 16Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, United Kingdom

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.16034

    • 0 abstract views
    • 0 PDF
  • P093 | GAINER-AI: PREDICTING ACUTE RIMEGEPANT RESPONSE IN MIGRAINE USING MACHINE LEARNING IN A MULTICENTER REAL-WORLD COHORT

    M. Romozzi1|2, A. Lokhawandala3, G. Vaghi4|5, G. Sebastianelli6, R. Ornello7, F. Casillo6, A. Russo8, M. Silvestro8, F. Pistoia9, G. Saporito9, G. Dalla Volta10, M. Bolchini10, A. Burgalassi11, G. Vigani11, D. Antonio Montisano12, L. Grazzi12, M. Pia Prudenzano13, D. Mascarella14, E. Mampreso15, G. Avino16, M. Valente17, G. Carlucci18, S. Guerzoni19, S. Battistini20, A. Granato21, E. Maria Piella22, I. Rainero22, M. Albanese23, M. Trimboli24, A. Doretti25, F. De Santis7, S. Sacco7, C. Tassorelli4|5, S. Di Tella26, C. Vollono1|2, P. Calabresi1|2, R. De Icco4|5, L. Francesco Iannone27 | 1Dipartimento Universitario di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy; 2Neurologia, Dipartimento di neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; 3Drexel University, Philadelphia, USA; 4Department of Brain and Behavioral Sciences, University of Pavia, Italy; 5Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy; 6Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino, Latina, Italy; 7Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 8Headache Centre, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy; 9Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Italy; 10Headache Center of Clinical Neurology of Istituto Clinico Città Di Brescia, Italy; 11Department of Health Sciences, University of Florence, Italy; 12Neuroalgology Unit and Headache Center, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy; 13Headache Center, Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy; 14IRCCS Istituto Di Scienze Neurologiche Di Bologna, Programma Cefalee e Algie Facciali, Italy; 15Headache Centre, Neurology - Euganea, Health Unit, Padua, Italy; 16Neurology Unit, Ospedale Santo Stefano, USL Toscana Centro, Prato, Italy; 17Clinical Neurology, Azienda Sanitaria Universitaria Friuli Centrale, Presidio Ospedaliero Santa Maria Della Misericordia, Udine, Italy; 18NEUROFARBA Department, University of Florence - AOU Careggi, Italy; 19Digital and Predictive Medicine, Pharmacology, Clinical Metabolic Toxicology-Headache Center and Drug Abuse, Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico, Modena, Italy; 20Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; 21Headache Centre, Clinical Unit of Neurology, School of Neurology, Department of Medicine, Surgery and Health Sciences, University Hospital and Health Services of Trieste, ASUGI, University of Trieste, Italy; 22Department of Neurosciences “Rita Levi Montalcini”, University of Turin, Italy; 23Unit of Neurology, Department of Systems Medicine, Tor Vergata University, Rome, Italy; Unit of Neurology - IRCCS Neuromed, Pozzilli (IS), Italy; 24Headache Centre, Neurology Unit, AOU Renato Dulbecco, Catanzaro, Italy; 25Department of Neurology- Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan, Italy; 26Dipartimento di Psicologia, Università Cattolica del Sacro Cuore, Milan, Italy; 27Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.16049

    • 1 abstract views
    • 0 PDF
1 - 6 of 6 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review

Categories

    • Contents

indexing

INDEXING
  • Scopus
  • OpenAlex
  • Analytics

Keywords

Confinia Cephalalgica

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS. eISSN 3035-0670 (Website continuously updated).

pISSN 1122-0279
eISSN 3035-0670

The journal

  • About the Journal
  • Editorial board
  • Archives
  • Announcements
  • Contact

For authors

  • Submissions
  • Guidelines for authors
  • Privacy Statement
PAGEPress

© PAGEPress 2008–2026. PAGEPress® is a registered trademark property of PAGEPress srl, Italy. VAT IT02125780185. This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.